KARACHI: Pakistan Stock Exchange above the 98,000 mark on Friday as share prices surged more than 2,000 points in intraday trade
ISLAMABAD: Drug Regulatory Authority of Pakistan (DRAP) has issued registration letters for import and manufacturing of Remdesivir used for critically ill patients of COVID-19.
According to spokesman Ministry of National Health Services, on increasing demand, approvals are issued to two importers and 14 local manufacturers.
He said Remdesivir is approved for emergency use in a special emergency meeting in order to ensure early availability.
You May Also Like
TEHRAN: The head of Iran’s Revolutionary Guards described the arrest warrant issued by the International Criminal Court for Israeli Prime
LOWER KURRAM: The death toll in yesterday’s gun attack on passenger vans in Khyber Pakhtunkhwa’s Lower Kurram has risen to 42,






